127 related articles for article (PubMed ID: 8318566)
1. Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
Motyl T; Traczyk Z; Holska W; Daniewska-Michalska D; Cieśluk S; Kukulska W; Kałuzny Z; Podgurniak M
Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):205-9. PubMed ID: 8318566
[TBL] [Abstract][Full Text] [Related]
2. Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthopterin, and pterin.
Rokos H; Rokos K; Frisius H; Kirstaedter HJ
Clin Chim Acta; 1980 Aug; 105(2):275-86. PubMed ID: 7398095
[TBL] [Abstract][Full Text] [Related]
3. Blood plasma pseudouridine in patients with malignant proliferative diseases.
Motyl T; Traczyk Z; Cieśluk S; Daniewska-Michalska D; Kukulska W; Kałuzny Z; Podgurniak M; Orzechowski A; Debski B
Eur J Clin Chem Clin Biochem; 1993 Nov; 31(11):765-71. PubMed ID: 8305621
[TBL] [Abstract][Full Text] [Related]
4. Urinary neopterin in malignant lymphoma.
Piccinini L; Zironi S; Federico M; Pini LA; Luppi G
Int J Biol Markers; 1991; 6(4):231-6. PubMed ID: 1795130
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of pseudouridine, neopterine and creatinine in urine by ion-pair high-performance liquid chromatography with in-series ultraviolet and fluorescence detection.
Palmisano F; Rotunno T; La Sorsa M; Zambonin CG; Abbate I
Analyst; 1995 Aug; 120(8):2185-9. PubMed ID: 7677252
[TBL] [Abstract][Full Text] [Related]
6. Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody.
Itoh K; Mizugaki M; Ishida N
Clin Chim Acta; 1989 May; 181(3):305-15. PubMed ID: 2758683
[TBL] [Abstract][Full Text] [Related]
7. Urinary neopterine in the assessment of lymphoid and myeloid neoplasia, and neopterine levels in haemolytic anaemia and benign monoclonal gammopathy.
Hausen A; Fuchs D; Grünewald K; Huber H; König K; Wachter H
Clin Biochem; 1982 Feb; 15(1):34-7. PubMed ID: 7067074
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
Rasmuson T; Björk GR
Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of urinary neopterin in non-Hodgkin's lymphomas.
Abate G; Comella P; Marfella A; Santelli G; Nitsch F; Fiore M; Perna M
Cancer; 1989 Feb; 63(3):484-9. PubMed ID: 2912527
[TBL] [Abstract][Full Text] [Related]
10. [Increased urinary excretion of neopterin in patients with malignant tumors and with virus diseases (author's transl)].
Wachter H; Hausen A; Grassmayr K
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1957-60. PubMed ID: 527945
[TBL] [Abstract][Full Text] [Related]
11. Urinary neopterin levels in hematologic malignancies.
Santelli G; Marfella A; Abate G; Comella P; Nitsch F; Perna M
Tumori; 1986 Apr; 72(2):139-43. PubMed ID: 3705186
[TBL] [Abstract][Full Text] [Related]
12. Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapy.
Tomandl J; Palyza V; Tallová J; Drbal J
J Exp Clin Cancer Res; 2004 Mar; 23(1):157-61. PubMed ID: 15149166
[TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
[TBL] [Abstract][Full Text] [Related]
14. Urinary neopterin in the diagnosis and follow-up of neoplasia: a biochemical parameter to detect cell-mediated immune response.
Fuchs D; Hausen A; Huber C; Reibnegger G; Wachter H
Tumour Biol; 1984; 5(3-4):199-209. PubMed ID: 6505550
[TBL] [Abstract][Full Text] [Related]
15. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
16. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
[TBL] [Abstract][Full Text] [Related]
17. Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion.
Honda I; Itoh K; Mizugaki M; Sasaki T
Tohoku J Exp Med; 1999 Jun; 188(2):133-8. PubMed ID: 10526874
[TBL] [Abstract][Full Text] [Related]
18. Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers.
Bonaccorso S; Lin AH; Verkerk R; Van Hunsel F; Libbrecht I; Scharpé S; DeClerck L; Biondi M; Janca A; Maes M
J Affect Disord; 1998 Feb; 48(1):75-82. PubMed ID: 9495605
[TBL] [Abstract][Full Text] [Related]
19. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma.
Piccinini L; Zironi S; Cenci AM; Campioli D; Federico M; Barbieri F
Eur J Clin Chem Clin Biochem; 1993 Sep; 31(9):567-74. PubMed ID: 8260527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
